首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Surgical pathology clinics

缩写:

ISSN:1875-9181

e-ISSN:1875-9157

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引633
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Matthew G Hanna Matthew G Hanna
The integration of digital and computational pathology into breast pathology practice is evolving the field. Leveraging machine learning, pathologists can augment their workflows in disease classification, biomarker quantification, and outc...
Theodore Vougiouklakis,Dara S Ross Theodore Vougiouklakis
Biomarker testing, multigene expression assays, and mutation profiling can be employed to direct treatment following the pathologic diagnosis of an invasive breast carcinoma. This article provides a summary for the surgical pathologist, und...
Melinda E Sanders Melinda E Sanders
Immunohistochemistry is utilized in all facets of diagnostic breast pathology. Recognition of aberrant E-cadherin expression in invasive lobular carcinoma and lobular carcinoma avoids misinterpretation. A context-focused battery of stains w...
Lauren Ashley Duckworth,Raza Syed Hoda Lauren Ashley Duckworth
This review examines prognostic and predictive molecular assays in invasive breast carcinoma beyond estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2. It highlights the clinical utility of multigene assa...
Joanna Solarewicz,Kimberly H Allison Joanna Solarewicz
Evolving data continue to require pathologists to adjust breast cancer biomarker interpretation and reporting. ER low positive and HER2 low/ultralow are not distinct subtypes of breast cancer but have important treatment implications. ER lo...
Sai K Maley,Reena Khiroya,Elena Provenzano et al. Sai K Maley et al.
Stromal tumor infiltrating lymphocytes (sTILs) in breast cancer is an easily evaluable histopathological biomarker that is shown to be robust and reproducible with prognostic and predictive value in triple negative breast cancer (TNBC), HER...
Anne Grabenstetter Anne Grabenstetter
High-risk lesions of the breast confer an increased risk for breast cancer. Due to wide variations in the reported rate of upgrade to carcinoma at excision, optimal management of these lesions is controversial. Intraductal papillomas, mucoc...
Zi Long Chow,Mihir Gudi,Puay Hoon Tan Zi Long Chow
The first part of the review of the fibroepithelial lesions of the breast discussed both fibroadenoma and phyllodes tumors (PTs), including their differential diagnoses. In this part of the review, the management, prognosis, and molecular u...
Zi Long Chow,Mihir Gudi,Puay Hoon Tan Zi Long Chow
Fibroepithelial lesions of the breast are neoplasms composed of epithelial and stromal elements. The ubiquitous fibroadenoma shows intracanalicular and pericanalicular growth patterns, along with other histologic changes. The subtypes of fi...